Acelrx Pharmaceuticals reported $27.54M in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acelrx Pharmaceuticals ACRX:US USD 27.54M 5.6M
Baxter International BAX:US USD 5.54B 3.32B
Becton, Dickinson and BDX:US USD 25.3B 192M
Cara Therapeutics CARA:US USD 184.82M 19.6M
Heron Therapeutics HRTX:US USD 22.45M 44.19M
Intra Cellular Therapies ITCI:US USD 685.42M 36.78M
Pain Therapeutics PTIE:US USD 198.72M 19.65M
Smiths SMIN:LN GBP 2.7B 446M
Teva Pharmaceutical TEVA:IT USD 8.77B 269M
Xeris Pharmaceuticals Inc XERS:US USD 55.04M 18.9M